Figure 3 | Scientific Reports

Figure 3

From: MicroRNAs as potential therapeutics to enhance chemosensitivity in advanced prostate cancer

Figure 3

Effects of siRNA knockdown of 51 gene targets of miR-217 or miR-181b-5p mimics on the docetaxel or cabazitaxel sensitivity of PC3 cells. Cells were treated with 10 nM docetaxel or 5 nM cabazitaxel after siRNA transfection. Barplots show viability of siRNA-transfected cells, with or without taxane treatment, relative to that of cells transfected with non-targeting siRNA control without taxane treatment. Datapoints are mean ± standard deviations of 4 replicate samples.

Back to article page